{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:11:34Z","timestamp":1759342294596},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.patbio.2005.07.009","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T13:03:55Z","timestamp":1127221435000},"page":"159-165","source":"Crossref","is-referenced-by-count":4,"title":["Maladie de Willebrand de type 2B et pseudomaladie de Willebrand de type 2B\u00a0; \u00e0 propos de trois observations"],"prefix":"10.1016","volume":"54","author":[{"given":"S.","family":"Guermazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Conard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Samama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Dellagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2005.07.009_bib1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.patbio.2005.07.009_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib3","first-page":"17784","article-title":"von Willebrand disease: a database of point mutations, insertions and deletions","volume":"69","author":"Ginsburg","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2003.00523.x","article-title":"Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works","volume":"2","author":"Ruggeri","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJM198202113060603","article-title":"Pseudo von Willebrand's disease: an intrinsic platelet defect with aggregation by unmodified human factor VIII\/von Willebrand factor and enhanced adsorption of its high molecular weight multimers","volume":"306","author":"Weiss","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2005.07.009_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Platelet-type von Willebrand's disease: characterization of a new bleeding disorder","volume":"60","author":"Miller","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib7","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1016\/0003-2697(66)90246-6","article-title":"Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies","volume":"15","author":"Laurell","year":"1966","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.patbio.2005.07.009_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJM197407182910301","article-title":"Inherited variants of factor VIII-related protein in von Willebrand\u2019s disease","volume":"291","author":"Peake","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.patbio.2005.07.009_bib9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1615883","article-title":"Structure and function of von Willebrand factor","volume":"82","author":"Ruggeri","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib10","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.patbio.2005.07.009_bib11","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V55.6.1056.1056","article-title":"Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers","volume":"55","author":"Hoyer","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.patbio.2005.07.009_bib13","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1016\/S0021-9258(18)54729-3","article-title":"The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII","volume":"266","author":"Wise","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.patbio.2005.07.009_bib14","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","article-title":"The complex multimeric composition of factor VIII\/ von Willebrand factor","volume":"57","author":"Ruggeri","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1647316","article-title":"Willebrand factor antigen is less sensitive than ristocetin cofactor for the diagnosis of type I von Willebrand disease: results based on an epidemiological investigation","volume":"64","author":"Rodeghiero","year":"1990","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high sheer stress: a study of 60 cases","volume":"81","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2002-27821","article-title":"Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15\u00a0year journey","volume":"28","author":"Favaloro","year":"2002","journal-title":"Semin Thromb Haemost"},{"key":"10.1016\/j.patbio.2005.07.009_bib19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1046\/j.1365-2516.2002.00683_1.x","article-title":"A duplex issue: (i) time to re-appraise the diagnosis and classification of von Willebrand disorder, and (ii) clarification of the roles of von Willebrand factor collagen binding and ristocetin cofactor activity assays","volume":"8","author":"Favaloro","year":"2002","journal-title":"Haemophilia"},{"key":"10.1016\/j.patbio.2005.07.009_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thromb. Res."},{"key":"10.1016\/j.patbio.2005.07.009_bib21","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib22","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/s-0037-1613140","article-title":"Changes in von Willebrand factor and factor VIII levels during the menstrual cycle","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0038-1648458","article-title":"Willebrand disease masquerading as haemophilia A","volume":"67","author":"Von Mazurier","year":"1992","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib25","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.86.10.3793","article-title":"Von Willebrand factor synthesised by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets","volume":"86","author":"De Groot","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.patbio.2005.07.009_bib26","series-title":"Manuel d'h\u00e9mostase","first-page":"311","article-title":"Maladie de Willebrand","author":"Fressinaud","year":"1995"},{"key":"10.1016\/j.patbio.2005.07.009_bib27","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1073\/pnas.82.21.7424","article-title":"Interaction of purified IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb\/IIIa complex and initiates aggregation","volume":"82","author":"De Marco","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.patbio.2005.07.009_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1055\/s-0038-1657699","article-title":"A type 2B von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype","volume":"78","author":"Federici","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.patbio.2005.07.009_bib29","first-page":"94","article-title":"Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment","volume":"88","author":"Castaman","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.patbio.2005.07.009_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653684","article-title":"Ristocetina new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thromb. Diath. Haemorrh."},{"key":"10.1016\/j.patbio.2005.07.009_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI113095","article-title":"Type 2B von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin","volume":"80","author":"De Marco","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.patbio.2005.07.009_bib32","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.88.11.4761","article-title":"Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease","volume":"88","author":"Miller","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.patbio.2005.07.009_bib33","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V81.7.1787.1787","article-title":"Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor","volume":"81","author":"Russell","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V85.3.727.bloodjournal853727","article-title":"Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease","volume":"85","author":"Takahashi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001721-199707000-00009","article-title":"De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease","volume":"8","author":"Kunishima","year":"1997","journal-title":"Blood Coagul. Fibrinol."},{"key":"10.1016\/j.patbio.2005.07.009_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V90.2.698","article-title":"Expression and functional characterisation of an abnormal platelet membrane glycoprotein Ib alpha (Met239\u2192Val) reported in patients with platelet type von Willebrand disease","volume":"90","author":"Moriki","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2005.07.009_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(77)91197-7","article-title":"1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand\u2019s disease","volume":"1","author":"Mannucci","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2005.07.009_bib38","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in type IIb von Willebrand\u2019s disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N. Engl. J. Med."}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036981140500115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036981140500115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T21:11:08Z","timestamp":1626556268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036981140500115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S036981140500115X"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2005.07.009","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}